Peter C. Haughney

1.1k total citations
20 papers, 715 citations indexed

About

Peter C. Haughney is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Peter C. Haughney has authored 20 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Rheumatology. Recurrent topics in Peter C. Haughney's work include Urologic and reproductive health conditions (4 papers), Prostate Cancer Treatment and Research (4 papers) and Sperm and Testicular Function (3 papers). Peter C. Haughney is often cited by papers focused on Urologic and reproductive health conditions (4 papers), Prostate Cancer Treatment and Research (4 papers) and Sperm and Testicular Function (3 papers). Peter C. Haughney collaborates with scholars based in United States and Switzerland. Peter C. Haughney's co-authors include Gerald R. Cunha, Simon W. Hayward, Ravinder Dahiya, Mark Rosen, Ana Rosa Cunha, L.S. Baskin, G. S. Prins, Barbara A. Foster, K.M. Greulich and Heinz‐Ulrich G. Weier and has published in prestigious journals such as British Journal of Cancer, Journal of Pharmacology and Experimental Therapeutics and Biology of Reproduction.

In The Last Decade

Peter C. Haughney

19 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter C. Haughney United States 13 350 323 127 115 90 20 715
A. Donjacour United States 7 444 1.3× 544 1.7× 172 1.4× 103 0.9× 164 1.8× 9 909
Benjamin T. Montgomery United States 8 564 1.6× 297 0.9× 122 1.0× 65 0.6× 149 1.7× 9 876
Daisuke Obinata Japan 21 324 0.9× 483 1.5× 98 0.8× 192 1.7× 90 1.0× 63 1.0k
Guo-Hai Shi China 16 371 1.1× 379 1.2× 67 0.5× 161 1.4× 17 0.2× 36 772
Masatoshi Moriyama Japan 13 328 0.9× 233 0.7× 32 0.3× 152 1.3× 34 0.4× 47 590
Mathilde Kaper United States 10 248 0.7× 275 0.9× 198 1.6× 245 2.1× 30 0.3× 17 891
Amy S. Woodard United States 7 237 0.7× 637 2.0× 18 0.1× 193 1.7× 107 1.2× 8 1.1k
Chiara Grisanzio United States 9 347 1.0× 768 2.4× 69 0.5× 304 2.6× 143 1.6× 11 1.1k
Tatsuya Shimomura Japan 9 265 0.8× 203 0.6× 27 0.2× 173 1.5× 23 0.3× 37 469
Jacqueline Stockley United Kingdom 17 229 0.7× 547 1.7× 18 0.1× 78 0.7× 97 1.1× 24 839

Countries citing papers authored by Peter C. Haughney

Since Specialization
Citations

This map shows the geographic impact of Peter C. Haughney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Haughney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Haughney more than expected).

Fields of papers citing papers by Peter C. Haughney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter C. Haughney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Haughney. The network helps show where Peter C. Haughney may publish in the future.

Co-authorship network of co-authors of Peter C. Haughney

This figure shows the co-authorship network connecting the top 25 collaborators of Peter C. Haughney. A scholar is included among the top collaborators of Peter C. Haughney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter C. Haughney. Peter C. Haughney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khanh, T., Laura Q.M. Chow, Karen L. Reckamp, et al.. (2021). First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors. The Oncologist. 26(11). 925–e1918. 30 indexed citations
2.
Loyet, Kelly M., Xiangdan Wang, Jihong Yang, et al.. (2014). Complement Inhibition in Cynomolgus Monkeys by Anti–Factor D Antigen-Binding Fragment for the Treatment of an Advanced Form of Dry Age-Related Macular Degeneration. Journal of Pharmacology and Experimental Therapeutics. 351(3). 527–537. 40 indexed citations
3.
Kamath, Amrita V., Victor Yip, Priyanka Gupta, et al.. (2014). Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice. mAbs. 6(6). 1631–1637. 15 indexed citations
4.
Wasserman, Scott M., Michael J. Koren, Robert P. Giugliano, et al.. (2014). Abstract 16270: Evaluation of the Relationship Between Evolocumab 140 mg Every Two Weeks and 420 mg Monthly Dosing Regimens. 130. 2 indexed citations
5.
Loyet, Kelly M., Manda Wong, Alyssa Morimoto, et al.. (2010). Anti-Factor D Fab Specifically Inhibits the Alternative Complement Pathway: In vitro Characterization and in vivo Effects Following Administration to Cynomolgus Monkeys. Investigative Ophthalmology & Visual Science. 51(13). 2980–2980. 1 indexed citations
6.
Campagne, Menno van Lookeren, Kenneth J. Katschke, Ping Wu, et al.. (2010). Targeting the Alternative Pathway of Complement in AMD With a Factor D Selective Antibody. Investigative Ophthalmology & Visual Science. 51(13). 4511–4511. 2 indexed citations
7.
Haughney, Peter C., John R. Lowe, Jeriza Rusit, et al.. (2005). Clinical Pharmacokinetics of Ranibizumab (LucentisTM) in Subjects With AMD. Investigative Ophthalmology & Visual Science. 46(13). 1383–1383. 7 indexed citations
8.
Gaudreault, Jacques, et al.. (2004). A Pharmacokinetic Model Describing Ocular And Systemic Disposition Of Ranibizumab In Rabbits. Investigative Ophthalmology & Visual Science. 45(13). 1854–1854. 2 indexed citations
9.
Damico, Lisa A., et al.. (2004). Pharmacokinetic study of ranibizumab (LucentisTM) following subconjunctival, intracameral and intravitreal administration in rabbits. Investigative Ophthalmology & Visual Science. 45(13). 3952–3952. 1 indexed citations
10.
Wang, Yuzhuo, Daniel Sudilovsky, Baohui Zhang, et al.. (2001). A human prostatic epithelial model of hormonal carcinogenesis.. PubMed. 61(16). 6064–72. 85 indexed citations
11.
Hayward, Simon W., et al.. (1999). The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment. The Prostate. 39(3). 205–212. 51 indexed citations
12.
Hayward, Simon W., et al.. (1999). The rat prostatic epithelial cell line NRP‐152 can differentiate in vivo in response to its stromal environment. The Prostate. 39(3). 205–212. 2 indexed citations
13.
Haughney, Peter C., Simon W. Hayward, Rajvir Dahiya, & Gerald R. Cunha. (1998). Species-Specific Detection of Growth Factor Gene Expression in Developing Murine Prostatic Tissue1. Biology of Reproduction. 59(1). 93–99. 18 indexed citations
14.
Hayward, Simon W., Peter C. Haughney, Mark Rosen, et al.. (1998). Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation. 63(3). 131–140. 146 indexed citations
15.
Hayward, Simon W., L.S. Baskin, Peter C. Haughney, et al.. (1996). Stromal Development in the Ventral Prostate, Anterior Prostate and Seminal Vesicle of the Rat. Cells Tissues Organs. 155(2). 94–103. 101 indexed citations
16.
17.
Dahiya, Ravinder, et al.. (1996). P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer. British Journal of Cancer. 74(2). 264–268. 25 indexed citations
18.
Hayward, Simon W., L.S. Baskin, Peter C. Haughney, et al.. (1996). Epithelial Development in the Rat Ventral Prostate, Anterior Prostate and Seminal Vesicle. Cells Tissues Organs. 155(2). 81–93. 117 indexed citations
19.
Dahiya, Rajvir, et al.. (1995). Regression of LNCaP human prostate tumor xenografts in athymic nude mice by 13-cis-retinoic acid and androgen ablation.. PubMed. 35(3). 487–98. 13 indexed citations
20.
Dahiya, Rajvir, Guoren Deng, Katherine Chen, et al.. (1995). Terms and techniques: New approach to hot-start polymerase chain reaction using Taq DNA polymerase antibody. Urologic Oncology Seminars and Original Investigations. 1(1). 42–46. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Donjacour Breakdown of academic impact, for papers by Benjamin T. Montgomery Breakdown of academic impact, for papers by Daisuke Obinata Breakdown of academic impact, for papers by Guo-Hai Shi Breakdown of academic impact, for papers by Masatoshi Moriyama Breakdown of academic impact, for papers by Mathilde Kaper Breakdown of academic impact, for papers by Amy S. Woodard Breakdown of academic impact, for papers by Chiara Grisanzio Breakdown of academic impact, for papers by Tatsuya Shimomura Breakdown of academic impact, for papers by Jacqueline Stockley
Rankless by CCL
2026